Karl Messlinger
Arzt
Hat mitgewirkt an:
-
The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
-
High‐dose phenylephrine increases meningeal blood flow through TRPV1 receptor activation and release of calcitonin gene‐related peptide
-
CGRP measurements in human plasma – a methodological study
-
The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system